Binding of 17-AAG at the ATP binding site of HSP90 results in functional inhibition of the chaperone. This results in misfolding and destabilization of the client proteins essential for survival of the malignant cell. Misfolded proteins are degraded through the ubiquitin-proteasome pathway. Illustration by A. Y. Chen.